It looks like science fiction. I found an interview with Dr. Jonathan Bright about new PARP inhibitors. Anyone knows anything about this matter? Its translated in english.
Extremely interesting. Rapamycin and metformin related. Secret molecule, heavily patented. Subscription on extending your Lifespan for 200-300% for 100 000$ per year. Again richest get privileges…
Upd.: I think its some kind of fake. Haven’t found any info about such doctor or even institutions. Strange, another articles from this source are pretty solid.
I took some screen shots of the article and uploaded them to Google Gemini with this prompt:
Find any scientific or clinical research that supports the claims made in this writeup
Google Gemini Response:
Based on a review of scientific literature and institutional databases as of early 2026, there is no scientific or clinical research that supports the specific claims made in this writeup.
The article appears to be a fabrication or “fake news” designed to mimic scientific reporting. It cites institutions, researchers, and publications that either do not exist or have been mismatched to create a veneer of credibility.
Here is a breakdown of the specific discrepancies and lack of evidence:
1. Non-Existent or Misidentified Institutions
“Everett Institute for Advanced Biomedical Research” (Boston): There is no record of a major biomedical research institute by this name in Boston or elsewhere.
“Redwood Center for Gerontological Studies at Western University” (San Diego): This is a geographical and institutional impossibility.
There is a “Western University of Health Sciences” in Pomona, CA, and a “California Western School of Law” in San Diego, but neither hosts a “Redwood Center for Gerontological Studies.”
The real “Redwood Center” (for Theoretical Neuroscience) is located at UC Berkeley, not in San Diego, and does not focus on gerontology (aging).
“European Institute for Molecular Biotechnology” (EIMB, Heidelberg): This appears to be a fictional mashup of two real, separate institutions:
The European Molecular Biology Laboratory (EMBL), which is headquartered in Heidelberg, Germany.
The Institute of Molecular Biotechnology (IMBA), which is located in Vienna, Austria.
2. No Record of the “Nature” Study
Claim: A study published in Nature in “mid-October 2024” by Dr. Jonathan Bright proved PARP inhibitors increase life expectancy.
Reality: A search of Nature publications from October 2024 reveals no such paper. While PARP inhibitors (like Olaparib) are well-known drugs used in oncology (e.g., for ovarian and breast cancer), there is no high-profile Nature paper from that period announcing they are a “key to significantly increasing life expectancy” in healthy organisms or that they have been successfully modified for rejuvenation.
Context: In fact, recent real-world research on PARP inhibitors often focuses on their toxicity and side effects (such as risks of secondary leukemia), rather than their use as safe anti-aging agents for the general population.
3. Unknown Researcher
“Dr. Jonathan Bright”: There is no prominent researcher by this name associated with major breakthroughs in PARP inhibitors or longevity science in the public record.
Conclusion
The text you provided bears the hallmarks of a generated or hoax article: it uses generic-sounding names (“Institute for Advanced Biomedical Research,” “Dr. Bright”) and mixes them with real scientific terms (PARP inhibitors, oxidative stress, mitochondria) to sound plausible to a lay audience. Do not base any health or investment decisions on this text.